Cells change their minds: how identity gets set, reset, traced, and reverted

Regeneration begins with a genome-wide shutdown

In a preprint posted to bioRxiv, researchers studying limb regeneration in pancrustaceans report that amputation triggers a genome-wide shutdown of enhancer-associated chromatin, marked by the loss of accessible regulatory regions and depletion of the histone marks H3K27ac and H3K4me1. The genome does not simply pick up where it left off; it first goes dark. m:…0746

What follows is a conserved sequence: selective reopening of regulatory elements and upregulation of the pioneer transcription factor Zelda, whose own locus is held in check by H3K27me3 and H3K9me3 in intact tissue. The researchers found this shutdown-then-reopen program conserved across the species studied, which suggests regeneration is an active resetting process rather than a passive repair of the pre-injury state. m:…0746

The shutdown-first order is the surprising part. A repair process that simply restored the pre-injury state would have no reason to erase enhancer accessibility genome-wide before rebuilding it. The reset-then-reopen sequence suggests the tissue treats injury as a licensing event: old regulatory programs are revoked before new ones are written, which may be what prevents a half-healed limb from growing into a confused mosaic of identities. m:…0746

Tracing who becomes what, at 90 percent coverage

A second preprint introduces scRIPT, a single-cell lineage-tracing method that combines RNP-based barcoding with reporter-based cell enrichment to reach a cell dropout rate of only about 10 percent, or 90 percent coverage, during short differentiation protocols such as the hematoendothelial differentiation of embryonic stem cells. m:…5791

Applied to fate decisions, the method found that bifurcating progenitors in hematoendothelial differentiation already express mRNA of canonical regulators of their eventual fate, and that clonal memory in differentiating embryonic stem cells is heritable, fate-independent, and enriched with imprinted genes. High-coverage tracing like this narrows the window in which fate is decided, moving the question from which cells diverge to what tips them. m:…5791

The 90 percent coverage figure is the method's real advance. Lineage tracing has been limited by barcode dropout that silently deletes the very branches researchers want to study, and high coverage turns lineage trees from sparse samples into near-censuses. That is what makes the early fate-bias observation trustworthy rather than anecdotal. m:…5791

One factor keeps a cell adult

A third preprint identifies ZBTB7B as the most connected transcription factor across human salivary samples, a master regulator of salivary acinar cell identity whose motifs mark salivary-specific enhancers that correlate with AQP5 expression, the water channel central to saliva secretion. m:…9446

Knocking it out in mice reduces salivary flow and canonical secreted proteins, and its loss induces a neonate-like acinar population with increased MHC class I expression. Adult identity, in other words, is actively maintained; remove the maintenance factor and the cell slides back to an earlier developmental state. m:…9446

Rewriting the marks of pluripotency

The fourth preprint perturbs the system pharmacologically. Treating embryonic stem cells with the KDM4 inhibitor QC6352 alters H3K9me3 distribution across repeat families in both Setdb1-intact and Setdb1-depleted cells, showing that a small molecule can redraw repressive chromatin on a broad scale. m:…7816

Two gene modules showed attenuation or reversal of Setdb1-associated expression changes after inhibition, but transcriptional responses differed between embryonic stem cells and embryoid bodies, a reminder that chromatin drugs act on a moving target: the same perturbation reads differently depending on developmental stage. m:…7816

The embryonic stem cell versus embryoid body difference is the cautionary note: a chromatin drug is not a switch with one output. Developmental context changes the readout, so any program built on KDM4 inhibition will have to map stage-specific responses rather than assume the stem-cell result transfers. m:…7816